Your Unread Messages
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
Second-line treatment for malignant pleural mesothelioma
Cancer Treatment Reviews, 11/05/09
Ceresoli GL et al. – Second–line therapy in MPM remains an ideal field in which to test new chemotherapy agents as well as new therapeutic strategies, including anti–angiogenic compounds, small molecules or monoclonal antibodies that target different molecular pathways.
Related Articles
Is malignant pleural mesothelioma a surgical disease? A review of 83 consecutive extra-pleural pneumonectomies
European Journal of Cardio-Thoracic Surgery, 10/14/09
Relevance Score: 80%
Late cutaneous metastases to the face from malignant pleural mesothelioma: A case report and review of the literature
World Journal of Surgical Oncology, 11/12/09
Relevance Score: 68%
Combined treatment with cisplatin and sirolimus to enhance cell death in human mesothelioma
The Journal of Thoracic and Cardiovascular Surgery, 10/27/09
Relevance Score: 67%
Pleural malignant mesothelioma with invasive micropapillary component and its association with pulmonary metastasis
Pathology International, 10/20/09
Relevance Score: 67%
A systematic approach to the investigation and diagnosis of a unilateral pleural effusion
International Journal of Clinical Practice, 10/15/09
Relevance Score: 67%
Today in Lung/Thoracic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma: Multi-Institutional Experience
Journal of Clinical Oncology, 11/24/09
Alcohol Consumption and Lung Cancer Risk in the Environment and Genetics in Lung Cancer Etiology (EAGLE) Study
American Journal of Epidemiology, 11/24/09
Modeling excess lung cancer risk among screened arm participants in the Mayo Lung Project
Cancer, 11/23/09
Today in Pharmacology/Therapy...keeping you current
Receive free subspecialty "5-minute updates" via email
Nuclear IRS-1 predicts tamoxifen response in patients with early breast cancer
Breast Cancer Research and Treatment, 11/24/09
Successful treatment of autoimmune and lymphoproliferative complications of patients with intrinsic B-cell immunodeficiencies with Rituximab
British Journal of Haematology, 11/24/09
Clinical efficacy of a bortezomib, cyclophosphamide, thalidomide, and dexamethasone (Vel-CTD) regimen in patients with relapsed or refractory multiple myeloma: a phase II study
Annals of Hematology, 11/24/09
Sponsor
Article Search
Sponsor
Sponsor


See All


